BERGEN BRUNSWIG CORP
8-K, 1999-04-19
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: BASSETT FURNITURE INDUSTRIES INC, 4, 1999-04-19
Next: BETHLEHEM CORP, 10QSB, 1999-04-19




                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549



                               ------------------







                                    FORM 8-K



                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934




Date of Report (Date of earliest event reported):  April 14, 1999





                           BERGEN BRUNSWIG CORPORATION
               (Exact Name of Registrant as Specified in Charter)



New Jersey                          1-5110                      22-1444512  
(State Or Other                   (Commission                  (IRS Employer
Jurisdiction Of                   File Number)               Identification No.)
Incorporation)




      4000 Metropolitan Drive, Orange, California                    92868      
- --------------------------------------------------------------------------------
      (Address of Principal Executive Offices)                    (Zip Code)







Registrant's telephone number, including area code   (714) 385-4000    





<PAGE>


Item 5.  Other Events.



         Bergen   Brunswig   Corporation   ("Bergen")   and   PharMerica,   Inc.
("PharMerica") have been named as defendants in a lawsuit commenced on April 14,
1999 by PMR Corp. in the Superior  Court of  California,  San Diego County.  The
complaint seeks, among other things, an injunction enjoining Bergen from closing
its proposed acquisition of PharMerica and general, special and punitive damages
relating  to  alleged  breaches  of  an  agreement  between  PMR  and  a  Bergen
subsidiary.  Bergen  believes that PMR's claims are without merit and intends to
vigorously contest the allegations in PMR's complaint.

         Statements in this Current  Report on Form 8-K regarding  future events
constitute  forward-looking  statements under the Private Securities  Litigation
Reform Act of 1995.  Forward-looking statements contained in this Current Report
on Form 8-K are  subject to certain  risks and  uncertainties  that could  cause
actual results to differ  materially from those implied by such  forward-looking
statements. For example, because of the uncertainty of all litigation, there can
be no  assurance  that Bergen and  PharMerica  will be  successful  in defending
against PMR's lawsuit.  Certain  additional risks associated with Bergen are set
forth in  reports  that  Bergen  has  filed  with the  Securities  and  Exchange
Commission,  including  Bergen's  Annual  Report on Form 10-K for the year ended
September 30, 1998.





<PAGE>


                                    SIGNATURE



          Pursuant to the  requirements of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                          BERGEN BRUNSWIG CORPORATION




                                          By:  /s/ Milan A. Sawdei
                                               _________________________________
                                               Milan A. Sawdei
                                               Executive Vice President
                                               Chief Legal Officer and Secretary

Date:  April 19, 1999




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission